Latest

Alzheimer’s disease

Featured Genetics Neurology Neuroscience

·July 24, 2023·4 min read

Protein Suppression: A Promising Route to Slow Alzheimer’s Progression

Researchers have made a breakthrough in Alzheimer's disease (AD) research by identifying a protein that could be key in slowing the disease's progression. They found that the protein Slingshot Homolog-1 (SSH1) inhibits the protective biological activity of Nuclear factor erythroid 2-related factor 2 (Nrf2), which normally defends the brain against oxidative damage.

Featured Neurology Neuroscience

·July 20, 2023·3 min read

Is A Fitness Supplement A Potential Ally Against Alzheimer’s?

Researchers have found that the muscle-building supplement HMB (beta-hydroxy beta-methylbutyrate), commonly used by bodybuilders, could help protect memory and slow the progression of Alzheimer's disease. Mouse studies showed HMB reduced Alzheimer's plaques and enhanced factors for neuronal growth, safeguarding learning and memory.

Featured Neurology Neuroscience

·July 19, 2023·5 min read

Inflammation Levels Linked to Future Dementia Risk

Researchers found a significant, albeit small, correlation between inflammation levels and the future risk of dementia. In a study involving data from nearly 500,000 participants of the UK Biobank, the team evaluated inflammatory biomarkers and their relation to cognitive performance and later dementia diagnosis.

Featured Neurology Neuroscience

·July 19, 2023·4 min read

Espresso: More Than Energy Buzz, it’s A Potential Defense Against Alzheimer’s

Recent in vitro research reveals that espresso may offer more than a caffeine jolt. The study indicates that certain compounds in espresso can inhibit tau protein aggregation, a process implicated in the development of Alzheimer’s disease.

Featured Neurology Neuroscience

·July 17, 2023·5 min read

Donanemab: A Promising Step Forward in Early-Stage Alzheimer’s Treatment

A third new Alzheimer's drug, donanemab, is set for FDA approval, marking a significant step in slowing the progression of the disease. However, these treatments, which work best in the disease's early stages, may not suffice for patients with advanced Alzheimer's.

Featured Neurology Neuroscience

·July 17, 2023·4 min read

Anti-Inflammatory Drugs: A Pathway to Alzheimer’s Treatment

A new study sheds light on how certain anti-inflammatory drugs may prove to be effective treatments for Alzheimer's disease (AD). The team zeroed in on a protein known as p38.

Featured Neurology Neuroscience

·July 16, 2023·6 min read

Crosswords and Computers: Mental Acuity Tasks Beat Socializing in Dodging Dementia

The study underlines the importance of active mental stimulation in reducing dementia risk in older adults.

Featured Neurology Neuroscience

·July 14, 2023·5 min read

Eyes on Alzheimer’s: Study Links Age-Related Sight Loss to Cognitive Decline

Vision impairment in those over 71 could be a potential risk factor for dementia, a new study suggests. By analyzing the National Health and Aging Trends Study (NHATS), the researchers found a notable association between sight loss and the prevalence of dementia among nearly 3,000 US participants.

Featured Neurology Neuroscience

·July 3, 2023·4 min read

Learning Capabilities Persist in Dementia Patients

Dementia patients can still learn new skills, challenging common misconceptions about the disease. The researcher exposed dementia sufferers to tablet computers for the first time and, despite memory decline, they progressively learned to use them independently.

This shows an older man lifting weights.

Featured Neurology Neuroscience

·July 3, 2023·6 min read

Resistance Training: A Valuable Ally Against Alzheimer’s Disease

Regular physical exercise, especially resistance training, can delay the onset of Alzheimer's disease. Using a mice model, the team demonstrated a reduction in Alzheimer's indicators, like beta-amyloid plaques, and normalized stress hormone levels, following resistance exercise training.

Featured Neurology Neuroscience

·July 1, 2023·5 min read

Artificial Intelligence is Transforming Early Detection of Dementia

Researchers developed CognoSpeak, an innovative AI tool that aims to streamline the diagnosis of dementia and Alzheimer’s. Utilizing virtual agents to engage patients in cognitive tests and analyzing their language and speech patterns, the tool provides a quick and efficient assessment.

Featured Neurology Neuroscience

·July 1, 2023·6 min read

Lecanemab Alzheimer’s Treatment Set for FDA Approval

Doctors are preparing to administer lecanemab, a promising new Alzheimer's disease treatment nearing FDA approval. This therapy, marketed as Leqembi, slows cognitive decline by extracting amyloid proteins from the brain, thus decreasing tau protein accumulation.

1 … 13 14 15 16 17 … 199

Alzheimer’s disease

Protein Suppression: A Promising Route to Slow Alzheimer’s Progression

Is A Fitness Supplement A Potential Ally Against Alzheimer’s?

Inflammation Levels Linked to Future Dementia Risk

Espresso: More Than Energy Buzz, it’s A Potential Defense Against Alzheimer’s

Donanemab: A Promising Step Forward in Early-Stage Alzheimer’s Treatment

Anti-Inflammatory Drugs: A Pathway to Alzheimer’s Treatment

Eyes on Alzheimer’s: Study Links Age-Related Sight Loss to Cognitive Decline

Learning Capabilities Persist in Dementia Patients

Resistance Training: A Valuable Ally Against Alzheimer’s Disease

Artificial Intelligence is Transforming Early Detection of Dementia

Lecanemab Alzheimer’s Treatment Set for FDA Approval

Brain’s Locus Coeruleus Revealed as Key to Sleep Transitions

New Method Maps Gene Activity in Living Human Brain

How Expectations Shape Our Gaze in a Changing World

Power in Relationships Increases Risk of Infidelity

Subscribe